Literature DB >> 33028713

Subclinical Genital Herpes Shedding in HIV/Herpes Simplex Virus 2-Coinfected Women during Antiretroviral Therapy Is Associated with an Increase in HIV Tissue Reservoirs and Potentially Promotes HIV Evolution.

Tajanna Stinn1, Steve Kuntz2, Dana Varon2, Meei-Li Huang3, Stacy Selke3, Samuel Njikan1, Emily S Ford2,4, Joan Dragavon3, Robert W Coombs2,3, Christine Johnston2,3,4, Marta E Bull5,6.   

Abstract

Antigen (Ag)-specific immune responses to chronic infections, such as herpes simplex virus type 2 (HSV-2) in HIV/HSV-coinfected persons, may sustain HIV tissue reservoirs by promoting T-cell proliferation but are poorly studied in women on antiretroviral therapy (ART). Mixed anogenital swabs and cervical secretions were self-collected by nine HIV/HSV-2-coinfected women during ART for 28 days to establish subclinical HSV DNA shedding rates and detection of HIV RNA by real-time PCR. Typical herpes lesion site biopsy (TLSB) and cervical biopsy specimens were collected at the end of the daily sampling period. Nucleic acids (NA) isolated from biopsy specimens had HIV quantified and HIV envC2-V5 single-genome amplification (SGA) and T-cell receptor (TCR) repertoires assessed. Women had a median CD4 count of 537 cells/μl (IQR: 483 to 741) at enrollment and HIV plasma viral loads of <40 copies/ml. HSV DNA was detected on 12% of days (IQR: 2 to 25%) from anogenital specimens. Frequent subclinical HSV DNA shedding was associated with increased HIV DNA tissue concentrations and increased divergence from the most recent common ancestor (MRCA), an indicator of HIV replication. Distinct predominant TCR clones were detected in cervical and TLSB specimens in a woman with frequent HSV DNA shedding, with mixing of minor variants between her tissues. In contrast, more limited TCR repertoire mixing was observed in two women with less frequent subclinical HSV DNA shedding. Subclinical HSV shedding in HIV/HSV-coinfected women during ART may sustain HIV tissue reservoirs via Ag exposure or HIV replication. This study provides evidence supporting further study of interventions targeting suppression of Ag-specific immune responses as a component of HIV cure strategies.IMPORTANCE Persons with HIV infection are frequently coinfected with chronic herpesviruses, which periodically replicate and produce viable herpes virions, particularly in anogenital and cervical tissues. Persistent protein expression results in proliferation of CD8+ and CD4+ T cells, and the latter could potentially expand and sustain HIV tissue reservoirs. We found HSV genital shedding rates were positively correlated with HIV DNA concentrations and HIV divergence from ancestral sequences in tissues. Our work suggests that immune responses to common coinfections, such as herpesviruses, may sustain HIV tissue reservoirs during suppressive ART, suggesting future cure strategies should study interventions to suppress replication or reactivation of chronic herpes infections.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  ART; HIV; HIV tissue reservoirs; HSV-2; coinfection; female genital tract; herpes simplex virus 2; human immunodeficiency virus

Mesh:

Substances:

Year:  2020        PMID: 33028713      PMCID: PMC7737750          DOI: 10.1128/JVI.01606-20

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  68 in total

1.  Antiretroviral-free HIV-1 remission and viral rebound after allogeneic stem cell transplantation: report of 2 cases.

Authors:  Timothy J Henrich; Emily Hanhauser; Francisco M Marty; Michael N Sirignano; Sheila Keating; Tzong-Hae Lee; Yvonne P Robles; Benjamin T Davis; Jonathan Z Li; Andrea Heisey; Alison L Hill; Michael P Busch; Philippe Armand; Robert J Soiffer; Marcus Altfeld; Daniel R Kuritzkes
Journal:  Ann Intern Med       Date:  2014-09-02       Impact factor: 25.391

2.  Tenofovir Gel for Prevention of Herpes Simplex Virus Type 2 Acquisition: Findings From the VOICE Trial.

Authors:  Jeanne M Marrazzo; Lorna Rabe; Cliff Kelly; Barbra Richardson; Carolyn Deal; Jill L Schwartz; Z M Chirenje; Jeanna Piper; Rhoda Ashley Morrow; Craig W Hendrix; Mark A Marzinke; Sharon L Hillier
Journal:  J Infect Dis       Date:  2019-05-24       Impact factor: 5.226

3.  Molecular basis of the interactions between herpes simplex viruses and HIV-1.

Authors:  G Palù; L Benetti; A Calistri
Journal:  Herpes       Date:  2001-07

Review 4.  Genital herpes.

Authors:  Rachna Gupta; Terri Warren; Anna Wald
Journal:  Lancet       Date:  2007-12-22       Impact factor: 79.321

5.  Rapidly cleared episodes of herpes simplex virus reactivation in immunocompetent adults.

Authors:  Karen E Mark; Anna Wald; Amalia S Magaret; Stacy Selke; Laura Olin; Meei-Li Huang; Lawrence Corey
Journal:  J Infect Dis       Date:  2008-10-15       Impact factor: 5.226

6.  Frequent reactivation of herpes simplex virus among HIV-1-infected patients treated with highly active antiretroviral therapy.

Authors:  Christine M Posavad; Anna Wald; Steven Kuntz; Meei Li Huang; Stacy Selke; Elizabeth Krantz; Lawrence Corey
Journal:  J Infect Dis       Date:  2004-07-13       Impact factor: 5.226

7.  A cluster-randomized trial of enhanced labor ward-based PMTCT services to increase nevirapine coverage in Lusaka, Zambia.

Authors:  Karen M Megazzini; Moses Sinkala; Sten H Vermund; David T Redden; Daniel W Krebs; Edward P Acosta; Joyce Mwanza; Robert L Goldenberg; Namwinga Chintu; Marc Bulterys; Jeffrey Sa Stringer
Journal:  AIDS       Date:  2010-01-28       Impact factor: 4.177

8.  Maternal HIV-1 DNA load and mother-to-child transmission.

Authors:  Nils D Arvold; Nicole Ngo-Giang-Huong; Kenneth McIntosh; Veera Suraseranivong; Boonyarat Warachit; Surachai Piyaworawong; Tikamporn Changchit; Marc Lallemant; Gonzague Jourdain
Journal:  AIDS Patient Care STDS       Date:  2007-09       Impact factor: 5.078

9.  HIV latency. Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection.

Authors:  Thor A Wagner; Sherry McLaughlin; Kavita Garg; Charles Y K Cheung; Brendan B Larsen; Sheila Styrchak; Hannah C Huang; Paul T Edlefsen; James I Mullins; Lisa M Frenkel
Journal:  Science       Date:  2014-07-10       Impact factor: 47.728

10.  Persistence of mucosal T-cell responses to herpes simplex virus type 2 in the female genital tract.

Authors:  C M Posavad; L Zhao; D E Mueller; C E Stevens; M L Huang; A Wald; L Corey
Journal:  Mucosal Immunol       Date:  2014-06-11       Impact factor: 7.313

View more
  2 in total

1.  Reduced and highly diverse peripheral HIV-1 reservoir in virally suppressed patients infected with non-B HIV-1 strains in Uganda.

Authors:  Samira Joussef-Piña; Immaculate Nankya; Sophie Nalukwago; Joy Baseke; Sandra Rwambuya; Dane Winner; Fred Kyeyune; Keith Chervenak; Bonnie Thiel; Robert Asaad; Curtis Dobrowolski; Benjamin Luttge; Blair Lawley; Cissy M Kityo; W Henry Boom; Jonathan Karn; Miguel E Quiñones-Mateu
Journal:  Retrovirology       Date:  2022-01-15       Impact factor: 4.602

2.  Antiviral Potential of Naphthoquinones Derivatives Encapsulated within Liposomes.

Authors:  Viveca Giongo; Annarita Falanga; Camilly P Pires De Melo; Gustavo B da Silva; Rosa Bellavita; Salvatore G De-Simone; Izabel C Paixão; Stefania Galdiero
Journal:  Molecules       Date:  2021-10-25       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.